[Clinical and economic analysis of Reslizumab use in the ... | 合法藥品大搜索

Read More

Read More

The manufacturer submitted reslizumab at a unit price of $640.00 per vial. The manufacturer's primary economic evaluation was a cost-utility analysis (CUA) ... Read More

由 J Lam 著作 · 2019 · 被引用 13 次 — Introduction: Poorly controlled severe eosinophilic asthma is difficult and costly to manage. Reslizumab, an add-on treatment for adults with severe eosinophilic ... Read More

由 S Han 著作 · 2019 · 被引用 4 次 — Objectives: We aimed to assess the cost-utility of reslizumab for patients with severe eosinophilic asthma uncontrolled with high-dose inhaled corticosteroids ... Read More

由 AS Kolbin 著作 · 2019 — Budget impact analysis showed a significant effect of reslizumab on reducing budget costs. If reslizumab is used in 4250 patients (an estimated ... Read More

由 SK Zyryanov 著作 · 2020 — Thus, the results of the clinical and economic study suggested that, basing on the cost-effectiveness analysis, reslizumab appeared to be the ... Read More

Cinqair (reslizumab) is a member of the interleukin inhibitors drug class and is commonly used for Asthma. Cinqair Prices. The cost for Cinqair intravenous solution ... Read More

Cinqair (reslizumab) is a prescription drug used to treat severe eosinophilic asthma in adults. You'll take it along with your other asthma drugs. Cinqair isn't used ... Read More

2016年5月12日 — Compare prices, print coupons and get savings tips for Reslizumab (Cinqair) and other Asthma drugs at CVS, Walgreens, and other ... Read More